In the Boardroom
Refine Search
Biotechnology
US-based biopharmaceutical company Nektar Therapeutics (Nasdaq: NKTR) has announced that Ivan Gergel will serve as the Company's new Senior Vice President, Drug Development & Chief Medical Officer effective immediately. 19 May 2014
Pharmaceutical
US drugmaker AbbVie (NYSE: ABBV) has named Michael Severino as Executive Vice President, Research and Development (R&D) and Chief Scientific Officer. 16 May 2014
Biosimilars
US generics major Actavis (NYSE: ACT) has announced the proposed senior management team that will lead the company pending the successful close of the acquisition of Forest Laboratories, anticipated mid-year. 14 May 2014
Biotechnology
US biotech firm Amgen has announced the appointment of Steven Galson to the position of senior vice president, Global Regulatory Affairs and Safety, effective May 19. 14 May 2014
Biotechnology
German biotech company Proteros has announced significant changes in its management team. 12 May 2014
Pharmaceutical
The Supervisory Board of Merck has elected Wolfgang Büchele as Chairman of its corporate governance body. 12 May 2014
Biotechnology
UK-based biopharmaceutical company Ario Pharma has announced the appointment of Professor Peter Barnes and Professor Wisia Wedzicha to its Scientific Advisory Board with immediate effect. 12 May 2014
Pharmaceutical
Germany’s Merck (MRK: DE) has appointed Marcus Kuhnert as Group Chief Financial Officer. Mr Kuhnert will become a member of Merck’s Executive Board with unlimited personal liability as of August 1, 2014. 9 May 2014
Pharmaceutical
Italian pharmaceutical company Menarini Group has announced that previous manager Dr Alberto Sergio Aleotti has passed away. 8 May 2014
Biotechnology
US-based Eleven Biotherapeutics (Nasdaq: EBIO), a clinical-stage biopharmaceutical company developing protein therapeutics to treat eye diseases, has announced the appointment of Gary Sternberg as Executive Vice President of Corporate and Business Development. 8 May 2014
Biotechnology
UK-based drug development services company Ergomed has announced the appointment of Rolf Stahel to its Board as Non-Executive Chairman. 7 May 2014
Biotechnology
Cobra Biologics is pleased to announce the appointment of Daniel Smith as Chief Scientific Officer with the responsibility of enhancing Cobra’s DNA, virus, microbial and mammalian proteins research and development platforms. 7 May 2014
Pharmaceutical
UK-based GW Pharmaceuticals has announced the appointment of Kenneth Sommerville to the newly created position of VP, Clinical Science, based in the USA. 7 May 2014
Pharmaceutical
US-based pharmacogenetics company Millennium Laboratories has announced the appointment of Nikhil Nayak as chief marketing officer, Steven Soe as chief compliance officer, and Michael Flowers as vice president, government operations. 6 May 2014
Pharmaceutical
Japanese drug major Astellas Pharma has announced the promotions of Bernhardt Zeiher to executive vice president, Global Development and Jeannette Barrett to vice president and head of Medical Excellence, Global Medical Affairs. 6 May 2014
Pharmaceutical
Australia-based QRxPharma has announced the appointment of Edward Rudnic as Chief Executive Officer with immediate effect. 2 May 2014
Biotechnology
UK-based cancer therapeutics firm Scancell has announced the appointment of Sally Adams to the board as Development Director with immediate effect. 1 May 2014
Biotechnology
UK nanotechnology firm Midatech has announced the appointments of Rolf Stahel as chairman and Craig Cook as Chief Operating Officer (COO) and Chief Medical Officer (CMO). 1 May 2014
Biotechnology
French nanomedicine company Nanobiotix has announced the appointment of Thierry Otin as Head of Manufacturing and Supply. 29 April 2014
Biotechnology
US biopharmaceutical company Coherus Biosciences has announced the appointment of Michael Fleming as senior vice president, commercial strategy. 28 April 2014
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze